Success of Big Infectious Disease Reimbursement Policy in China
Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government's intervention in large-scale infectious diseases is successful and efficient. Two potential stra...
Saved in:
Main Authors: | Kun-xi Nie (Author), Chan Wang (Author), Xin-wu Li (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges and opportunities for pharmaceutical pricing and reimbursement policies
by: Sabine Vogler, et al.
Published: (2015) -
Pharmaceutical pricing and reimbursement policies: perspectives for the future
by: Andrew L Gray
Published: (2015) -
Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
by: Hong Zhu, et al.
Published: (2022) -
Balancing medical innovation and affordability in the new healthcare ecosystem in China: Review of pharmaceutical pricing and reimbursement policies
by: Vivian Chen, et al.
Published: (2023) -
Evaluation of the implementation effect of hepatitis C medical insurance reimbursement policy in China: A RWS based on medical institutions
by: Yiyao Liu, et al.
Published: (2023)